The present study was performed to investigate whether TRPC6 participated in Ca 2+ signaling of glomerular mesangial cells (MCs) and expression of this protein was altered in diabetes. Western blots and real-time PCR were used to evaluate the expression level of TRPC6 protein and mRNA, respectively. Cell-attached patch clamp and fura-2 fluorescence measurements were utilized to assess angiotensin II (Ang II)-stimulated membrane currents and Ca 2+ responses in MCs. In cultured human MCs, high glucose significantly reduced expression of TRPC6 protein, but there was no effect on either TRPC1 or TRPC3. The high glucose-induced effect on TRPC6 was time and dose dependent with the maximum effect observed on day 7 and at 30 mM glucose, respectively. In glomeruli isolated from streptozotocin-induced diabetic rats, TRPC6, but not TRPC1, was markedly reduced compared to the glomeruli of control rats. Furthermore, TRPC6 mRNA in MCs was also significantly decreased by high glucose as early as one day after treatment with maximal reduction on day 4. Patch clamp experiments showed that Ang II-stimulated membrane currents in MCs were significantly attenuated or enhanced by knockdown or overexpression of TRPC6, respectively. Fura-2 fluorescence measurements revealed that the Ang II-induced 
INTRODUCTION
Diabetic nephropathy (DN) is a major and devastating complication of diabetes. At the very onset of diabetes, a dominant pathophysiological characteristic is the development of renal glomerular hyperfiltration (2; 39) . This early hemodynamic phenotype provokes the subsequent demise of a diabetic kidney. Diabetic hyperfiltration is derived from a combination of decreased responsiveness of both the renal afferent arterioles and glomerular mesangial cells (MCs) to vasoconstrictors (2; 3; 20; 29; 42) . MCs, located within glomerular capillary loops, physiologically regulate glomerular hemodynamics (26; 37). In diabetes, mesangial contractile function is impaired, and reduced Ca 2+ influx is believed to be a major contributing factor to the hypocontractility (29; 42). However, the underlying molecular mechanism(s) responsible for the impaired Ca 2+ signaling remains poorly understood.
Hyperglycemia is the main determinant of initiation and progression of diabetic microvascular complications including nephropathy (13; 38) . In vitro and in vivo studies have demonstrated that high glucose or hyperglycemia directly stimulates MCs, which subsequently results in mesangial dysfunction or malfunction (20; 23; 24; 29; 42). However, the mechanisms by which hyperglycemia causes nephropathy are still not well defined.
4 glomerular podocytes has been reported to be tightly linked to hereditary familial focal segmental glomerulosclerosis and acquired forms of proteinuric kidney diseases (27; 43). In a recent study, we demonstrated that TRPC6 is also abundantly expressed in human and rat MCs (36) , which possess similar contractile phenotype and biophysical properties to those in vascular smooth muscle cells. However, the physiological and pathophysiological relevance of TRPC6 in MCs is completely unknown.
In the present study, we tested the hypothesis that the TRPC6 channel protein mediates vasoconstrictor-induced Ca 2+ responses in MCs and the expression of this protein is downregulated by high glucose or hyperglycemia in diabetes.
MATERIALS AND METHODS

Generating diabetic rats. Male Sprague-Dawley rats (~ 8 weeks) were purchased from
Harlan (Indianapolis, IN 46229). Diabetes was induced by intraperitoneal injection of streptozotocin (STZ) at 65 mg/kg body weight in sodium citrate buffer (0.01 M, pH 4.5). An equivalent amount of sodium citrate buffer alone was used as a vehicle control. Blood glucose levels were monitored 24 h later and periodically thereafter (LifeScan One Touch glucometer,
Johnson & Johnson, Milpitas, CA) by rat-tailed blood sampling. STZ-injected rats with sustained elevation of blood glucose above 300 mg/dl were designated as diabetic rats. All rats had unrestricted access to food and water and were maintained in accordance with
Institutional Animal Care and Use Committee procedures of the University of North Texas
Health Science Center.
Isolation of glomeruli.
On day 14 after STZ or vehicle injection, all rats were euthanized, and both kidneys were removed. Glomeruli were isolated by differential sieving of minced renal cortex. Finely chopped kidney cortex in Hank's balanced salt solution (pH 7.4) was pressed through sequentially smaller metal sieves and collected on a final sieve of 63 µm pore size (mini-sieve set, Scienceware Co., Pequannock, NJ 07440). Following three alternate washes and centrifugations, the pellets of glomeruli were solubilized in a lysis buffer and the supernatants were collected for Western blot.
MC culture and transient transfection. Human MCs were purchased from Cambrex
Company (New Jersey). MCs were subcultured to no more than ten generations by standard ] i in MCs using fura-2 were performed using dual excitation wavelength fluorescence microscopy. MCs, grown on a coverslip (22×22 mm), were loaded with fura-2 by incubation for ~50 min at room temperature in the dark in physiological saline solution containing 2 µM acetoxymethyl ester of fura-2 (fura-2/AM), 0.09 g/dl DMSO, and 0.018 g/dl Pluronic F-127 (Molecular Probes, Eugene, OR) followed by washing 3 times with physiological saline solution. The cells were then incubated with fura-2 free physiological saline solution for an additional ~20 min. The coverslip was then placed in a perfusion chamber (Warner, Model RC-2OH) mounted on the stage of a Nikon Diaphot inverted microscope. Fura-2 fluorescence was monitored by a ratio technique (excitation at 340 and 380 nm, emission at 510 nm) using Metafluor software (Universal Imaging, West Chester, PA).
Western Blot. Performed as described in our previous publication (36) . In brief, protein extracts of glomeruli or MC lysates were fractionated by 10% SDS-PAGE, transferred to PVDF antibodies. All stainings were visualized using confocal laser scanning microscopy (Zeiss LSM410).
Quantitative real time RT-PCR. The total RNA was isolated from MCs or glomeruli using a Versagene RNA kit following the manufacturer's protocol (Gentra System, Inc., Minneapolis).
Tagman primers and probes for trpc1, trpc4, trpc6, and -actin were designed according to their respective human DNA sequences ( , where CT = C T, TRPC -C T, actin and ( C T ) = C T, normal glucose -C T, high glucose . were used to analyze the differences among multiple groups, between two groups, and before and after treatment in the same group, respectively. P<0.05 was considered statistically significant. Statistical analysis was performed using SigmaStat (Jandel Scientific, San Rafael, CA). To determine the physiological relevance of the TRPC6 channel protein in MCs, cell-attached patch clamp experiments were performed to measure single channel currents in response to
Materials
Ang II in human MCs that were cultured in normal glucose medium (5.6 mM) and were transiently transfected with rat trpc6 expression plasmids (pEF-BOS-TRPC6A) or hTRPC6-shRNA constructs. GFP was co-transfected at amounts of 10 times less for identifying positively transfected cells. As shown in Fig. 1A and B, application of Ang II (1 µM) into the bath increased the channel activity in MCs of all three groups. However, the channel activation was strikingly enhanced in the cells with overexpression of TRPC6 (606 ± 76% and 229 ± 33%, TRPC6 overexpression vs. Mock, p<0.05), but blunted in the cells with knockdown of TRPC6 (51 ± 6% and 229 ± 33%, hTRPC6-shRNA vs. Mock, p<0.05, Fig. 1A and B). In addition, the basal activity of the channels was significantly raised by overexpression of TRPC6, but was not affected by knockdown of TRPC6 (Fig. 1A) . Overexpression of TRPC6
protein by transient transfection with pEF-BOS-TRPC6A was verified by Western blot in human MCs (Fig. 1E) . The specificity and efficiency of hTRPC6-shRNA constructs were confirmed by real time RT-PCR, which showed that the RNAi constructs significantly reduced the mRNA expression of TRPC6, but not TRPC1 or TRPC4 in MCs (Fig. 1F ). These data suggest that TRPC6 channels play an important role in mediating agonist-stimulated cation influxes in MCs. However, at resting state, this channel might be relatively quiet. and high glucose (30 mM) using the same protocol as described in Fig. 1C . In accordance with knockdown of TRPC6, high glucose treatment markedly attenuated the Ang II-stimulated Ca 2+ entry (dashed boxes in Fig. 2A and B) . Averaged data from 8 cells of each group showed a significant difference in the agonist-induced Ca 2+ influxes (Fig. 2C) . These results strongly suggest that the vasoconstrictor-induced Ca 2+ response in MCs is impaired by high glucose. time dependent with a significant inhibition as early as 2 days after incubation and the maximal effect was seen on day 7 ( Fig. 3 A and B) . Thereafter, TRPC6 protein was sustained at a significantly lower level for the entire observation period of 28 days. Furthermore, glucose also displayed a dose-dependent effect on TRPC6 expression ( Fig. 3 C and D) . At 10 mM of glucose for 7 days, the amount of TRPC6 protein had a tendency to decrease. Significant reduction of TRPC6 protein occurred at 20 mM concentration of glucose with a further decease at 30 mM for the same time period of incubation (7 days). The high glucose-induced reduction of TRPC6 protein expression seems to be MC specific because no difference in TRPC6
protein expression was observed in conditionally immortalized mouse podocytes between normal (5 mM) and high glucose (25 mM) treatments (Fig. 3E ).
Our previous study demonstrated that human MCs also express TRPC1, TRPC3, and TRPC4 (36) . To determine whether the high glucose effect is specific for TRPC6, we measured the protein expression levels of TRPC1 and TRPC3 in MCs cultured in 5 mM and 30 mM glucose for 7 days. As shown in Fig. 4 A and B, high glucose did not affect the expression of TRPC1 or TRPC3, but TRPC6 only.
Furthermore, to determine if the decrease in TRPC6 protein is a specific effect of glucose treatment, we re-cultured the MCs, which had been exposed to high glucose for 7 days, in 5 mM glucose medium for additional 3 days. Under this condition, the high glucose-induced reduction of TRPC6 expression was nearly restored (Fig. 4 C) .
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Taken together, these biochemical results strongly suggest that high glucose specifically downregulated TRPC6 protein expression in cultured MCs. We then examined whether diabetes changed the expression level of the TRPC6 protein in glomeruli. Since MCs constitute one third of the glomerular cell population (26), the changes in the TRPC6 protein in MCs are expected to be detectable at the level of the entire glomeruli. Glomeruli were isolated from the kidneys of normal and STZ-induced diabetic rats.
STZ-induced diabetes was demonstrated by slow increase in body weight, sustained elevation of blood glucose, and high urine output following STZ injection (Table 2 ). Figure 6C shows the purity of isolated glomeruli which is estimated to be >99%. Crude proteins were extracted from the normal and diabetic glomeruli and subsequently, were loaded for Western blot. In agreement with the results from the MCs cultured in high glucose, the amount of the TRPC6 protein was dramatically reduced in diabetic glomeruli. However, the TRPC1 expression level did not have a discernible change ( Fig. 6 A and B) . Since MC is a major type of glomerular cells and high glucose did not affect TRPC6 protien expression in glomerular podocytes (Fig.   3E ), we inferred that the reduction of TRPC6 protein in diabetic glomeruli can most likely be attributed to the diseased MCs. (Fig. 7B ). These data suggest that high glucose or hyperglycemia in diabetes downregulated the TRPC6 protein expression by negative regulation of TRPC6 gene expression. (Fig. 1B) , implying that TRPC6 protein might be the channel or a critical component of the channel complexes mediating the Ang II-stimulated membrane response.
DISCUSSION
These findings suggest that deficiency of the TRPC6 protein might be an underlying mechanism for the hyperfiltration seen in the early stages of diabetes. Interestingly, knockdown of TRPC6 did not affect the basal channel activity of MCs (Fig. 1A) , implying that the TRPC6 channel might not be important in maintaining tonic mesangial tone at the resting state. Since human MCs possess multiple isoforms of TRPC channel proteins (36), we inferred that the resting tone of MCs might be the function of those TRPC isoforms or could be mediated by other types of ion channels in the plasma membrane. Indeed, we recently found that the biological knockdown of TRPC1 using an RNAi approach or functional blockade of TRPC1 channel using a specific TRPC1 antibody significantly reduced basal membrane currents in cultured MCs (8).
Recently, the physiological and pathophysiological relevance of TRPC6 in kidney glomeruli has drawn intense attention from many investigators. In a recent study from Dr. Reiser's group, TRPC6 was detected and characterized as a component of the slit diaphragm multiprotein complex of glomerular podocytes, suggesting that it functions as a critical regulator of normal renal function (32). This speculation was validated by two discoveries that gain-in-function mutations in the TRPC6 gene in glomerular podocytes cause hereditary familial focal segmental glomerulosclerosis (43) and that upregulation of TRPC6 in podocytes results in acquired forms of proteinuric kidney disease (27). Using immunohistochemistry, we found that the TRPC6 protein also existed in human and rat glomerular MCs ( Fig. 5 and (36) ). Moreover, the results from the present study display a link between high glucose or hyperglycemia and deficiency of TRPC6 protein expression in glomerular MCs, suggesting a potential implication of TRPC6 in the development of DN. We believe that the high glucose-induced downregulation is specific for TRPC6 because TRPC1 and TRPC3 protein expression levels were not affected by high glucose (Fig. 3 A and B ) and the TRPC1 protein did not have any significant change in the diabetic glomeruli compared with the controls (Fig. 6A) . Also, TRPC6 downregulation is a specific effect of high glucose because the reduction of the TRPC6 protein showed a clear dose-dependence on the concentration of glucose (Fig. 3C) , and replacement of high glucose with normal glucose in culture medium could restore the decreased TRPC6 expression at both decrease in TRPC6 mRNA level (Fig. 7) and oxidative damage to DNA in diabetes mellitus has been reported (4).
In summary, our findings from the present study imply that TRPC6 is an important channel mediating agonist-stimulated mesangial contraction, and this channel protein is significantly reduced in diabetes. The importance of these findings is to provide a possible molecular mechanism for glomerular hyperfiltration, a characteristic of diabetes mellitus at the early stage, and thereby provide a new clue for therapeutic targets to slow down the progression of DN. 
F: forward primer; R: reverse primer; P: probe Quantification of the TRPC1 and TRPC6 proteins from three repeated experiments. *:
significant difference compared to corresponding Con group. C: Glomeruli isolated from normal rat kidneys using sieving technique. 
